28 Apr Jurors to resume lengthy deliberations in opioid bribes case
BOSTON — Jurors will head back to court to continue deliberating in the case against a wealthy drug company founder accused of directing a scheme to bribe doctors to prescribe a powerful opioid.
Jurors will begin their 12th day of deliberations on Monday in the case against Insys Therapeutics Founder John Kapoor and four other former executives of the Chandler, Arizona-based company.
They are accused of conspiring to bribe doctors to boost sales for a highly addictive fentanyl spray meant for cancer patients with severe pain.
All of them have denied wrongdoing.
Two other former high-level Insys executives pleaded guilty in the case and testified against Kapoor.
Jurors haven’t asked the judge any questions since they began deliberating on April 8. The trial began in January.
rn{% endblock %}"},"start":"https://users.startribune.com/placement/1/environment/3/limit-signup-optimizely/start"},{"id":"limit-signup","count":12,"action":"ignore","mute":true,"action_config":{"template":"{% extends "grid" %}rnrn{% block heading_text %}Youu2019ve read your 10 free articles for this 30 day period. Sign up now for local coverage you wonu2019t find anywhere else, special sections and your favorite columnists. StarTribune puts Minnesota and the world right at your fingertips. {% endblock %}rnrn{% block last %}rn{{ parent() }}rn{# limit Krux pixel from https://www.squishlist.com/strib/customshop/328/ #}rn
rnrn{% endblock %}"},"start":"https://users.startribune.com/placement/1/environment/3/limit-signup/start"},{"id":"meter-desktop-331","count":10,"action":"ignore","mute":false,"action_config":false,"start":"https://users.startribune.com/placement/1/environment/3/meter-desktop-331/start"},{"id":"PDA991499opt","count":9,"action":"ignore","mute":true,"action_config":false,"start":"https://users.startribune.com/placement/1/environment/3/PDA991499opt/start"},{"id":"limit","count":8,"action":"inject","mute":false,"action_config":{"template":"
rnrnrnrn
rn
rn t
rn rn
rn
rn
rn
rn
rn"},"start":"https://users.startribune.com/placement/1/environment/3/limit/start"},{"id":"nag","count":7,"action":"lightbox","mute":true,"action_config":{"height":null,"width":"630px","redirect_on_close":null,"template":"{% extends "shell" %}rnrn{% block substyles %}rn
rn{% endblock %}rnrn{% block page %}rn{#rnrn{{ limit - count - 1 }}rnrn{{ form.flow_form_open({nextAction: 'firstSlide'}, null, null, '_top') }}rn {{ form.btn('Save Now') }}rn{{ form.flow_form_close() }}rnrn
rnrnrnu2022 rnrn }}){kind=logo}
rnrn#}rn
You have {{ limit - count - 1 }} articles left
rn
rn rn u00a0u00a0u2022u00a0u00a0rn rn
rn
rn
rn  }})
rn
Over 70% off!
rn
 }}){kind=logo}
rn rn
rn
99u00a2 for first 4 weeks
rn {{ form.flow_form_open({nextAction: 'firstSlide'}, null, null, '_top') }}rn {{ form.button('Save Now', 'btn nag-btn') }}rn {{ form.flow_form_close() }}rn
rn
rn{% endblock %}rnrn{% block last %}rn{{ parent() }}rnrn{% endblock %}"},"start":"https://users.startribune.com/placement/1/environment/3/nag/start"},{"id":"x","count":4,"action":"ignore","mute":true,"action_config":false,"start":"https://users.startribune.com/placement/1/environment/3/x/start"},{"id":"multi-start","count":3,"action":"fly_in","mute":true,"action_config":{"location":"bottom_left","slide_direction":"bottom","group_id":null,"display_delay":"0","collapse_delay":"10","template":"
rn
"},"start":"https://users.startribune.com/placement/1/environment/3/multi-start/start"}]};
[ad_2]
Source link
No Comments